ACCESS PHARMACEUTICALS, INC.
SBIR Phase I
STTR Phase I
N/ASTTR Phase I 2000 Department of Health and Human Services
Chemical Casualty Care: Hydrogel Nanoparticle Aggregates as Wound Dressings Following Debridement of Cutaneuous Vesicant InjuriesAmount: $69,988.00
The proposed research will demonstrate the utility of hydrogel nanoparticle aggregates as bandages for post-debridement vesicant injuries. Dehydrated hydrogel nanoparticles in powder form are applied ...SBIR Phase I 2005 ArmyDepartment of Defense